Whalesbook
Borosil Scientific Approves Stock Options Grant
Borosil Scientific has approved the grant of 18,700 employee stock options (ESOPs) at Rs 108 per option.
Reader Takeaway: An employee incentive plan is active, with potential for future share dilution.
What Happened
The Nomination and Remuneration Committee (NRC) of Borosil Scientific met on May 20, 2026. During the meeting, they approved granting 18,700 employee stock options under the company's existing scheme. Each option allows the holder to apply for one equity share of Re. 1 face value.
The set grant price for these options is Rs 108 each. This price reflects approximately a 10% discount compared to the market price on May 19, 2026.
Why This Matters
This grant of stock options is designed to incentivize employees by aligning their interests with the company's performance. It signals the company's commitment to retaining and motivating key staff through ownership stakes. However, existing shareholders should be aware that the exercise of these options could lead to future equity dilution.
Scheme Details and Timeline
Employees who receive these options will follow a vesting schedule. A portion of their options will vest each year over four years, with 25% vesting annually. Once vested, employees have a five-year window to exercise their options.
Shareholder Considerations
Existing shareholders will want to watch for potential dilution if many employees exercise their options. The success of this incentive hinges on the company's stock performance; employees are most likely to exercise options when the market price is higher than the Rs 108 grant price.
Key Metrics
- Total Options Granted: 18,700
- Grant Price: Rs 108 per option
- Market Price (approx.): Rs 120 (as of May 19, 2026)
- Vesting: 25% annually over 4 years
- Exercise Period: 5 years post-vesting
- Committee Meeting Date: May 20, 2026
Next Steps for Investors
Investors should monitor how quickly these options are exercised and the resulting issuance of new shares. Tracking Borosil Scientific's financial results and stock price movement relative to the grant price will be important.